MK SeikoMK SEIKO CO., LTD.5906東証スタンダード金属製品FY ending Mar 2026, consolidated, J-GAAP

MK Seiko revenue and profit

Out of every ¥100 of sales, about ¥9 is left as operating profit. Revenue changed +5.4% from the prior year, operating profit +36.6%.

Five-year trend

Revenue¥29.8B
FY ending Mar 2022: ¥24.9B¥24.9BFY ending Mar 2023: ¥27.3B¥27.3BFY ending Mar 2024: ¥28.5B¥28.5BFY ending Mar 2025: ¥28.3B¥28.3BFY ending Mar 2026: ¥29.8B¥29.8BFY22FY23FY24FY25FY26
Operating income¥2.72B
FY ending Mar 2022: ¥1.08B¥1.08BFY ending Mar 2023: ¥1.69B¥1.69BFY ending Mar 2024: ¥2.13B¥2.13BFY ending Mar 2025: ¥1.99B¥1.99BFY ending Mar 2026: ¥2.72B¥2.72BFY22FY23FY24FY25FY26
Operating margin9.1%
FY ending Mar 2022: 4.3%4.3%FY ending Mar 2023: 6.2%6.2%FY ending Mar 2024: 7.5%7.5%FY ending Mar 2025: 7.1%7.1%FY ending Mar 2026: 9.1%9.1%FY22FY23FY24FY25FY26

What drives ROE

Net margin × asset turnover = ROA; ROA × financial leverage = ROE

Net margin7.9%
Asset turnover1.09×
ROA8.6%
ROA8.6%
Financial leverage1.71×
ROE14.8%

Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.

Net margin7.9%
2022: 2.3%2.3%2023: 4.3%4.3%2024: 2.5%2.5%2025: 4.7%4.7%2026: 7.9%7.9%2223242526
Asset turnover1.09×
2022: 0.97×0.97×2023: 1.05×1.05×2024: 1.07×1.07×2025: 1.07×1.07×2026: 1.09×1.09×2223242526
ROA8.6%
2022: 2.2%2.2%2023: 4.5%4.5%2024: 2.7%2.7%2025: 5.0%5.0%2026: 8.6%8.6%2223242526
Financial leverage1.71×
2022: 2.12×2.12×2023: 2.06×2.06×2024: 1.97×1.97×2025: 1.84×1.84×2026: 1.71×1.71×2223242526
ROE14.8%
2022: 4.7%4.7%2023: 9.3%9.3%2024: 5.3%5.3%2025: 9.3%9.3%2026: 14.8%14.8%2223242526
PeriodNet marginAsset turnoverROAFinancial leverageROE
20222.3%0.97×2.2%2.12×4.7%
20234.3%1.05×4.5%2.06×9.3%
20242.5%1.07×2.7%1.97×5.3%
20254.7%1.07×5.0%1.84×9.3%
20267.9%1.09×8.6%1.71×14.8%

Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.

Asset intensity and goodwill

Annual trends in tangible-asset ratios and goodwill balance.

PPE ÷ revenue17.7%
2021: 24.7%24.7%2022: 24.5%24.5%2023: 21.6%21.6%2024: 17.4%17.4%2025: 17.9%17.9%2026: 17.7%17.7%212223242526
PPE ÷ total assets18.6%
2021: 25.2%25.2%2022: 23.9%23.9%2023: 22.3%22.3%2024: 18.5%18.5%2025: 19.3%19.3%2026: 18.6%18.6%212223242526
Goodwill ÷ parent equity0.1%
2021: 7.6%7.6%2022: 4.8%4.8%2023: 3.2%3.2%2024: 1.7%1.7%2025: 0.7%0.7%2026: 0.1%0.1%212223242526
Goodwill balance¥19.4M
2021: ¥877.6M¥877.6M2022: ¥577.1M¥577.1M2023: ¥420M¥420M2024: ¥232.3M¥232.3M2025: ¥101.5M¥101.5M2026: ¥19.4M¥19.4M212223242526

Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition

Investment and working-capital efficiency

Track R&D investment and how long operating capital remains tied up before sales turn into cash.

R&D spending¥924.6M
2021: ¥783.6M¥783.6M2022: ¥809.9M¥809.9M2023: ¥841M¥841M2024: ¥916.8M¥916.8M2025: ¥938.4M¥938.4M2026: ¥924.6M¥924.6M212223242526
R&D / revenue3.1%
2021: 3.1%3.1%2022: 3.3%3.3%2023: 3.1%3.1%2024: 3.2%3.2%2025: 3.3%3.3%2026: 3.1%3.1%212223242526
Receivable days—
2021: 79d79d2022: 72d72d212223242526
Payable days17d
2021: 23d23d2022: 30d30d2023: 28d28d2024: 24d24d2025: 18d18d2026: 17d17d212223242526

R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.

Income statement (JPY millions)

ItemFY ending Mar 2022FY ending Mar 2023FY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
Revenue24,85627,32828,47428,26829,788
Cost of revenue16,79118,64819,26019,09319,533
Gross profit8,0648,6809,2149,17610,255
SG&A6,9846,9857,0877,1827,532
Operating income1,0811,6942,1271,9932,723
Pretax income1,0401,7191,4202,0243,116
Income tax473551706689762
Net income attributable to owners5661,1687141,3352,354
Operating margin4.3%6.2%7.5%7.1%9.1%

Balance sheet (reported items)

Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.

Assets

Cash 9%
Property, plant and equipment 19%
2%
Investment securities 12%
Other assets 58%

Funding

3%
Other liabilities 28%
Equity 69%
0%

Each bar totals 100% of assets; other is the residual.

ItemFY ending Mar 2022FY ending Mar 2023FY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
Cash and equivalents¥1.49B¥1.9B¥2.42B¥2.52B¥2.54B
Total assets¥25.5B¥26.5B¥26.8B¥26.3B¥28.3B
Net assets¥12.4B¥13.8B¥15B¥16.7B¥19.4B
Share capital¥3.37B¥3.37B¥3.37B¥3.37B¥3.37B
Trade receivables¥4.92B————
Property, plant and equipment¥6.09B¥5.89B¥4.96B¥5.07B¥5.26B
Intangible assets excluding goodwill¥1.51B¥1.3B¥997.5M¥778.9M¥631.1M
Goodwill¥577.1M¥420M¥232.3M¥101.5M¥19.4M
Investment securities¥1.68B¥1.75B¥2.21B¥2.42B¥3.33B
Current assets¥15.3B¥16.6B¥17.4B¥16.8B¥17.5B
Current liabilities¥10.2B¥10.2B¥9.9B¥7.08B¥6.08B
Trade payables¥1.38B¥1.41B¥1.29B¥930.4M¥892.7M
Short-term borrowings¥3.03B¥2.04B¥1.6B¥1.28B¥490M
Long-term borrowings¥2.01B¥1.66B¥1.03B¥1.49B¥1.55B
Total liabilities¥13.1B¥12.7B¥11.7B¥9.59B¥8.93B
Equity attributable to owners of parent¥12B¥13.2B¥13.8B¥15B¥16.9B
Retained earnings¥6.2B¥7.34B¥7.91B¥9.13B¥11.3B
Treasury stock-¥473.8M-¥451M-¥429.4M-¥408.9M-¥755.8M

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第70期(2025/03/21-2026/03/20)

    ID S100YA6U2026-06-11Open
  • EDINET (FSA Japan)

    有価証券報告書-第69期(2024/03/21-2025/03/20)

    ID S100VX2E2025-06-12Open
  • EDINET (FSA Japan)

    有価証券報告書-第68期(2023/03/21-2024/03/20)

    ID S100TMWM2024-06-18Open
  • EDINET (FSA Japan)

    有価証券報告書-第67期(2022/03/21-2023/03/20)

    ID S100QXCJ2023-06-13Open
  • EDINET (FSA Japan)

    有価証券報告書-第66期(令和3年3月21日-令和4年3月20日)

    ID S100O8CW2022-06-14Open
  • EDINET (FSA Japan)

    有価証券報告書-第65期(令和2年3月21日-令和3年3月20日)

    ID S100LIRT2021-06-15Open

Extracted from XBRL: 52 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.